SNTI
Senti Biosciences Holdings, Inc.
A biotech company that builds cells engineered with "gene circuits" — biological software programmed in so the cells can sense, compute, and respond much like a computer. Its therapies target hard-to-treat cancers, and the engineered cells are designed to attack tumors while sparing healthy tissue. Founded in 2016 by synthetic-biology pioneers, the name "Senti" comes from the cells' ability to "sense" their environment.
CUSIP: 81726A1001 holder
Total Value
$1.15M
Total Shares
1.83M
Net Share Change
-71.7K
Activity
1 selling
Investor
Value
Shares
Weight
Change
